Clinical Trial Update: Sacubitril/Valsartan in Resistant Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sacubitril/valsartan for resistant hypertension has completed, with the update noting the study status and results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Resistant Hypertension

Drugs mentioned

• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: Hospital Geral Roberto Santos | Conditions: Resistant Hypertension, Blood Pressure | Phase 2 | Status: COMPLETED